Miguel Torres‐Martín

University of Miami — United States

Medicine · Health Sciences

18h-index2.5kcitations99works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(39), Hepatitis B Virus Studies(35), Hepatocellular Carcinoma Treatment and Prognosis(20), Neurofibromatosis and Schwannoma Cases(19), Meningioma and schwannoma management(14)

Publications99 total

Unique epigenomic signatures identify biologically significant subtypes of MDS and predict response to azacitidine
2025Open Access
iPSC-based merlin-deficient Schwann cell-like spheroids as an in vitro system for studying NF2 pathogenesis
Genes & Diseases·2025· 1 citedOpen Access
Maternal ancestry reveals cyclical aging of the mammary gland.
2024Open Access
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
JHEP Reports·2024· 3 citedOpen Access
OS-026-YI Functional role of CD44+ cancer stem cells in intrahepatic cholangiocarcinoma
Journal of Hepatology·2024· 1 cited
Stellate cell-specific adhesion molecule protocadherin 7 regulates sinusoidal contraction
Hepatology·2024· 5 citedOpen Access
Supplementary Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023Open Access
Supplementary Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023Open Access
Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023Open Access
Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023Open Access
Supplementary Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023Open Access
Supplementary Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023Open Access
Data from Identification of <i>IGF2</i> as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma
2023Open Access
Data from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
2023Open Access
Supplementary Figure from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
2023Open Access
Supplementary Figure from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
2023Open Access
Supplementary Figure from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
2023Open Access
Supplementary Data from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
2023Open Access
Data from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
2023Open Access
Supplementary Figure from Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Daniela Sia(22), Josep M. Llovet(20), Juan A. Rey(18), Carla Montironi(14), Philipp K. Haber(14), Javier S. Castresana(14), Luis Lassaletta(13), Swan N. Thung(12), Augusto Villanueva(11), Marc Puigvehí(11), Roser Pinyol(10), Judit Peix(10), Laura Torrens(10), Alberto Isla(10), Carmen Andreu-Oller(9), José M. de Campos(9), Wei Qiang Leow(8), Miho Maeda(8), Vincenzo Mazzaferro(8), Bárbara Meléndez(8)